Literature DB >> 17767600

The child with recurrent respiratory infections: normal or not?

M de Martino1, S Ballotti.   

Abstract

Respiratory infections (RI) are one of the major complaints in children and adolescents, and represent a demanding challenge for the pediatrician. It has been estimated that at least 6% of Italian children younger than 6 yr of age present recurrent respiratory infections (RRI). Children with RRI are not affected by severe alterations of the immune system. RRI represent essentially the consequence of an increased exposure to infectious agents during the first years of life, when immune functions are still largely immature. Several social and environmental factors, such as day-care attendance, family size, air pollution, parental smoking, and home dampness, represent important risk factors for airway diseases and may contribute in various degrees to determine the incidence of RRI. The main problem for the pediatrician is to discriminate normal children with high RI frequency related to an augmented exposure to environmental risk factors from children affected by other underlying pathological conditions (immunological or not), predisposing to infectious diseases. When RRI diagnosis has been formulated, removal of environmental risk factors (i.e. precocious day-care attendance, smoking in the household) must first be suggested.

Entities:  

Mesh:

Year:  2007        PMID: 17767600     DOI: 10.1111/j.1399-3038.2007.00625.x

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN: 0905-6157            Impact factor:   6.377


  20 in total

Review 1.  Role of biofilm in children with recurrent upper respiratory tract infections.

Authors:  E Nazzari; S Torretta; L Pignataro; P Marchisio; S Esposito
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-10-16       Impact factor: 3.267

Review 2.  Oral Astragalus (Huang qi) for preventing frequent episodes of acute respiratory tract infection in children.

Authors:  Guobin Su; Xiankun Chen; Zhuangzhu Liu; Lihong Yang; Cecilia Stålsby Lundborg; Zehuai Wen; Xinfeng Guo; Xindong Qin; Jueyao Liang; Xusheng Liu
Journal:  Cochrane Database Syst Rev       Date:  2016-12-01

3.  Safety and efficacy of Yupingfeng granules in children with recurrent respiratory tract infection: A randomized clinical trial.

Authors:  Baoping Xu; Xinmin Li; Siyuan Hu; Yixiao Bao; Fengmei Chen; Zhimin Chen; Yonggang Du; Enmei Liu; Yufeng Liu; Qinghui Mou; Baoling Su; Bo Wang; Jianwen Xu; Guiping Xu; Qiaozhi Yang; Liwei Gao; Xiaohui Liu; Lei Li; Rong Ma; Kunling Shen
Journal:  Pediatr Investig       Date:  2022-06-02

Review 4.  Acupoint Herbal Patching for Long-Term Immune Function in Children with Recurrent Respiratory-Tract Infections: A Systematic Review of Real-World Data.

Authors:  Chan-Young Kwon; Boram Lee; Gyu Tae Chang
Journal:  Med Acupunct       Date:  2021-04-19

5.  Reduced numbers of switched memory B cells with high terminal differentiation potential in Down syndrome.

Authors:  Rita Carsetti; Diletta Valentini; Valentina Marcellini; Marco Scarsella; Emiliano Marasco; Ferruccio Giustini; Andrea Bartuli; Alberto Villani; Alberto G Ugazio
Journal:  Eur J Immunol       Date:  2014-12-28       Impact factor: 5.532

6.  Pidotimod: the past and the present.

Authors:  Gian Vincenzo Zuccotti; Chiara Mameli
Journal:  Ital J Pediatr       Date:  2013-12-06       Impact factor: 2.638

7.  A randomized, placebo-controlled, double-blinded, single-centre, phase IV trial to assess the efficacy and safety of OM-85 in children suffering from recurrent respiratory tract infections.

Authors:  Susanna Esposito; Sonia Bianchini; Samantha Bosis; Claudia Tagliabue; Ilaria Coro; Alberto Argentiero; Nicola Principi
Journal:  J Transl Med       Date:  2019-08-23       Impact factor: 5.531

8.  Effects of Pidotimod on recurrent respiratory infections in children with Down syndrome: a retrospective Italian study.

Authors:  Diletta Valentini; Chiara Di Camillo; Nadia Mirante; Valentina Marcellini; Rita Carsetti; Alberto Villani
Journal:  Ital J Pediatr       Date:  2020-03-13       Impact factor: 2.638

9.  Risk factors for recurrent respiratory tract infection in preschool-aged children.

Authors:  Bo Zhou; Wenquan Niu; Fangyu Liu; Yuan Yuan; Kundi Wang; Jing Zhang; Yunfeng Wang; Zhixin Zhang
Journal:  Pediatr Res       Date:  2020-11-10       Impact factor: 3.756

Review 10.  Respiratory Tract Infections and the Role of Biologically Active Polysaccharides in Their Management and Prevention.

Authors:  Milos Jesenak; Ingrid Urbancikova; Peter Banovcin
Journal:  Nutrients       Date:  2017-07-20       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.